New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

by Van Andel Research InstituteCredit: Unsplash/CC0 Public DomainA pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers
Breakthroughs March 30,2024
Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

by Van Andel Research InstituteCredit: Unsplash/CC0 Public DomainA pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers
Breakthroughs March 30,2024
Follow-up colonoscopy rate low within six months of abnormal stool test

Follow-up colonoscopy rate low within six months of abnormal stool test

by Elana GotkineFewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study publis
Breakthroughs March 30,2024
Follow-up colonoscopy rate low within six months of abnormal stool test

Follow-up colonoscopy rate low within six months of abnormal stool test

by Elana GotkineFewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study publis
Breakthroughs March 30,2024
Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

by Boston University School of MedicineCasual dose-response curves of FBG, HDL, and adiponectin with annualized memory change. The x-axis represents the values of biomarkers. The y-axis represent
Breakthroughs March 30,2024
Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

Sex-specific blood biomarkers linked to memory changes in middle-aged adults: The Framingham heart study

by Boston University School of MedicineCasual dose-response curves of FBG, HDL, and adiponectin with annualized memory change. The x-axis represents the values of biomarkers. The y-axis represent
Breakthroughs March 30,2024
Improving the world's most potent cancer drug

Improving the world's most potent cancer drug

by University of Tennessee at KnoxvilleElizabeth Barker. Credit: Shawn Poynter, University of TennesseeFourteen mice scurried around in laboratory cages, eating, sniffing, and running peacefully.
Breakthroughs March 30,2024
Improving the world's most potent cancer drug

Improving the world's most potent cancer drug

by University of Tennessee at KnoxvilleElizabeth Barker. Credit: Shawn Poynter, University of TennesseeFourteen mice scurried around in laboratory cages, eating, sniffing, and running peacefully.
Breakthroughs March 30,2024
Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

by Impact Journals LLCAnalysis of immune cell subsets during neoadjuvant therapy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28567A new research paper was published inOncotarg
Breakthroughs March 30,2024
Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

Durvalumab and Tremelimumab before surgery in patients with HR+/HER2-negative breast cancer

by Impact Journals LLCAnalysis of immune cell subsets during neoadjuvant therapy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28567A new research paper was published inOncotarg
Breakthroughs March 30,2024
Predicting weight gain in children using second generation anti-psychotic medication

Predicting weight gain in children using second generation anti-psychotic medication

by Laurie Fickman,University of HoustonCredit: CC0 Public DomainA new study from University of Houston College of Pharmacy researchers examined the development and predictors of clinically signi
Breakthroughs March 30,2024
Predicting weight gain in children using second generation anti-psychotic medication

Predicting weight gain in children using second generation anti-psychotic medication

by Laurie Fickman,University of HoustonCredit: CC0 Public DomainA new study from University of Houston College of Pharmacy researchers examined the development and predictors of clinically signi
Breakthroughs March 30,2024
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

by St. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainResistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Chil
Breakthroughs March 30,2024
Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

Study flips treatment paradigm in bilateral Wilms tumor, shows resistance to chemotherapy may be good

by St. Jude Children's Research HospitalCredit: Pixabay/CC0 Public DomainResistance to chemotherapy is typically associated with poor outcomes for patients with cancer. However, St. Jude Chil
Breakthroughs March 30,2024
FDA approves Winrevair for pulmonary arterial hypertension in adults

FDA approves Winrevair for pulmonary arterial hypertension in adults

by Lori SolomonThe U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.The FDA previously granted
Breakthroughs March 30,2024
FDA approves Winrevair for pulmonary arterial hypertension in adults

FDA approves Winrevair for pulmonary arterial hypertension in adults

by Lori SolomonThe U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.The FDA previously granted
Breakthroughs March 30,2024
Researchers discover a mechanism that could improve platinum-based cancer therapy

Researchers discover a mechanism that could improve platinum-based cancer therapy

by CU Anschutz Medical CampusCredit: CC0 Public DomainResearchers have identified a protein that, when targeted, enables cisplatin-resistant cancer cells to become responsive to treatment. Cispla
Breakthroughs March 30,2024
Researchers discover a mechanism that could improve platinum-based cancer therapy

Researchers discover a mechanism that could improve platinum-based cancer therapy

by CU Anschutz Medical CampusCredit: CC0 Public DomainResearchers have identified a protein that, when targeted, enables cisplatin-resistant cancer cells to become responsive to treatment. Cispla
Breakthroughs March 30,2024
Prolonged use of certain hormone drugs linked to increased brain tumor risk

Prolonged use of certain hormone drugs linked to increased brain tumor risk

by British Medical JournalMeningiomas are graded by microscopic appearance, rate of growth and tendency to invade other tissues. Credit: National Cancer InstituteProlonged use of certain progesto
Breakthroughs March 30,2024
Prolonged use of certain hormone drugs linked to increased brain tumor risk

Prolonged use of certain hormone drugs linked to increased brain tumor risk

by British Medical JournalMeningiomas are graded by microscopic appearance, rate of growth and tendency to invade other tissues. Credit: National Cancer InstituteProlonged use of certain progesto
Breakthroughs March 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com